Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomet 3i is a prominent global provider of dental reconstructive devices and oral health solutions. The company specializes in the design and manufacture of dental implants, abutments, and bone grafting materials used in restorative dentistry. Known for its OSSEOTITE and T3 implant technologies, Biomet 3i focuses on enhancing osseointegration and long-term clinical success for patients with missing teeth. Following the 2015 merger of Zimmer and Biomet, the company now operates as part of the Zimmer Biomet Dental division. Its portfolio also includes digital dentistry tools and regenerative products to support comprehensive oral rehabilitation. The company maintains a strong focus on clinical research and evidence-based outcomes to drive innovation in the dental implant market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomet 3i.